APA (7th ed.) Citation

Furugaki, K., Fujimura, T., Sakaguchi, N., Watanabe, Y., Uchibori, K., Miyauchi, E., . . . Yoshiura, S. Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK‐inhibitor‐induced tolerant persister cells in ALK‐fusion‐positive lung cancer. Wiley.

Chicago Style (17th ed.) Citation

Furugaki, Koh, Takaaki Fujimura, Narumi Sakaguchi, Yasutaka Watanabe, Ken Uchibori, Eisaku Miyauchi, Hidetoshi Hayashi, Ryohei Katayama, and Shigeki Yoshiura. Combined Blockade of GPX4 and Activated EGFR/HER3 Bypass Pathways Inhibits the Development of ALK‐inhibitor‐induced Tolerant Persister Cells in ALK‐fusion‐positive Lung Cancer. Wiley.

MLA (9th ed.) Citation

Furugaki, Koh, et al. Combined Blockade of GPX4 and Activated EGFR/HER3 Bypass Pathways Inhibits the Development of ALK‐inhibitor‐induced Tolerant Persister Cells in ALK‐fusion‐positive Lung Cancer. Wiley.